Loading financial statements…
Import this data to Google Sheets with:
=jivedata("AUBN","financials")Full statements spill as a table. For one cell: =jivedata("AUBN","Revenue") or =jivedata("AUBN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
AUBN • CIK 0000750574
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $1,395 | $6,397 | $7,255 | $8,388 |
| Weighted Average Number of Shares Outstanding, Basic | 3,498,030 | 3,493,690 | 3,493,699 | 3,493,162 |
| Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements | — | — | 1,337 | 2,467 |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | 3,495,036 | 3,495,629 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Due from Banks | $27,127 | $15,142 | $22,335 | $20,009 |
| Federal Funds Sold | $31,412 | $37,200 | $21,322 | $37,953 |
| Interest-bearing Deposits in Banks and Other Financial Institutions | $12,830 | $41,012 | $104,175 | $153,687 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $71,369 | $93,354 | $147,832 | $211,649 |
| Debt Securities, Available-for-sale | $270,910 | $243,012 | $233,259 | $220,744 |
| Financing Receivable, Held-for-Sale | — | — | $172 | $716 |
| FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest | $6,863 | $6,871 | $7,176 | $6,586 |
| FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss | $550,431 | $557,146 | $558,178 | $573,003 |
| Property, Plant and Equipment, Net | $45,535 | $45,931 | $45,600 | $44,856 |
| Bank Owned Life Insurance | $17,110 | $17,513 | $17,927 | $17,955 |
| Other Assets | $19,900 | $20,368 | $15,829 | $16,880 |
| Assets | $975,255 | $977,324 | $1,018,797 | $1,085,803 |
| Federal Funds Purchased and Securities Sold under Agreements to Repurchase | $1,486 | $1,486 | — | $0 |
| Other Liabilities | $1,019 | $3,208 | $3,818 | $3,611 |
| Liabilities | $898,748 | $899,032 | $926,744 | $991,929 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $39 | $39 | $39 | $39 |
| Additional Paid in Capital, Common Stock | $3,801 | $3,802 | $3,864 | $3,871 |
| Retained Earnings (Accumulated Deficit) | $113,398 | $115,759 | $119,241 | $121,852 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-29,029 | $-29,607 | $-19,390 | $-19,993 |
| Treasury Stock, Common, Value | $11,702 | $11,701 | $11,701 | $11,895 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $76,507 | $78,292 | $92,053 | $93,874 |
| Noninterest-bearing Deposit Liabilities | $270,723 | $260,874 | $268,026 | $258,351 |
| Interest-bearing Deposit Liabilities | $625,520 | $634,950 | $654,900 | $729,967 |
| Deposits | $896,243 | $895,824 | $922,926 | $988,318 |
| Preferred Stock, Shares Authorized | 200,000 | 200,000 | 200,000 | 200,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 8,500,000 | 8,500,000 | 8,500,000 | 8,500,000 |
| Common Stock, Shares, Issued | 3,957,135 | 3,957,135 | 3,957,135 | 3,959,302 |
| Treasury Stock, Common, Shares | 463,521 | 463,436 | 463,436 | 471,472 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $1,395 | $6,397 | $7,255 | $8,388 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $71,369 | $93,354 | $147,832 | $175,349 |
| FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal | $135 | $36 | $631 | $204 |
| Depreciation, Depletion and Amortization, Nonproduction | $1,700 | $1,933 | $2,113 | $2,190 |
| Accretion (Amortization) of Discounts and Premiums, Investments | $-2,380 | $-1,505 | $-1,377 | $-1,336 |
| Deferred Income Tax Expense (Benefit) | $-195 | $438 | $-129 | $-129 |
| Gain (Loss) on Investments | $-6,295 | $0 | — | $0 |
| Gain (Loss) on Sale of Mortgage Loans | $71 | $261 | $154 | $254 |
| Payments for Origination of Mortgage Loans Held-for-sale | $4,141 | $10,439 | $7,074 | $9,331 |
| Proceeds from Sale of Mortgage Loans Held-for-sale | $4,174 | $10,622 | $7,005 | $8,967 |
| Gain (Loss) on Disposition of Property Plant Equipment | $3,234 | — | — | $3,234 |
| Life Insurance, Corporate or Bank Owned, Change in Value | $359 | $403 | $414 | $419 |
| Share-based Payment Arrangement, Noncash Expense | — | — | $62 | $91 |
| Increase (Decrease) in Other Operating Assets | $-2,652 | $1,168 | $-995 | $-190 |
| Increase (Decrease) in Operating Liabilities | $-2,011 | $2,149 | $682 | $466 |
| Net Cash Provided by (Used in) Operating Activities | $11,902 | $10,809 | $12,349 | $11,631 |
| Proceeds from Sale of Debt Securities, Available-for-sale | $111,269 | $0 | — | $0 |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $30,329 | $25,620 | $22,020 | $22,025 |
| Payments to Acquire Debt Securities, Available-for-sale | $0 | — | — | $0 |
| Payments for (Proceeds from) Loans and Leases | $52,892 | $6,709 | $1,735 | $17,637 |
| Payments to Acquire Property, Plant, and Equipment | $418 | $2,089 | $1,485 | $1,485 |
| Payments for (Proceeds from) Federal Home Loan Bank Stock | $164 | $-32 | $0 | $29 |
| Proceeds from Life Insurance Policy | $216 | $0 | — | — |
| Proceeds from Sale of Property, Plant, and Equipment | $4,222 | — | — | $4,222 |
| Proceeds from Sale of Foreclosed Assets | $536 | — | — | $536 |
| Net Cash Provided by (Used in) Investing Activities | $91,377 | $16,854 | $18,800 | $3,358 |
| Net Change Noninterest-bearing Deposits, Domestic | $-40,648 | $-9,849 | $7,152 | $-10,117 |
| Net Change Interest-bearing Deposits, Domestic | $-13,446 | $9,430 | $19,950 | $58,584 |
| Increase (Decrease) in Federal Funds Purchased and Securities Sold under Agreements to Repurchase, Net | $-1,065 | $-1,486 | $0 | $0 |
| Payments for Repurchase of Common Stock | $229 | $0 | — | — |
| Payments of Ordinary Dividends | $3,776 | $3,773 | $3,773 | $3,772 |
| Net Cash Provided by (Used in) Financing Activities | $-59,164 | $-5,678 | $23,329 | $44,501 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $44,115 | $21,985 | $54,478 | $59,490 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $7,516 | $11,520 | $11,155 | $10,806 |
| Income Taxes Paid, Net | $1,230 | $1,244 | $676 | $748 |